
Bristol-Myers Squibb Co BMY.N:
BRISTOL MYERS SQUIBB PROVIDES UPDATE ON PHASE 3 RELATIVITY-098 TRIAL
BRISTOL-MYERS SQUIBB CO - BMS PHASE 3 RELATIVITY-098 TRIAL FAILS TO MEET PRIMARY ENDPOINT
BRISTOL-MYERS SQUIBB CO - OPDULAG SAFETY PROFILE CONSISTENT WITH KNOWN PROFILES
Source text: ID:nBw4sPyPCa
Further company coverage: BMY.N